This White Paper draws on the expertise of 10 senior Medical Affairs leaders across diverse global organizations to describe the role of Medical Affairs in ensuring the MedTech industry meets the challenges of high-quality evidence, objective measures, changes in the healthcare landscape, and more.
In this episode, we hear from RWE and industry experts on the importance of early alignment of your evidence generation plan and medical strategy and how to integrate RWE into your publication plan.
In today’s episode, we speak with Chris Medieros about how to maximize your organization’s presence and impact at congresses.
In today’s episode, we’ll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy
This second episode in the series discusses the activities of the External Education FAWG and the different learning opportunities that are currently available and coming soon to all MAPS members.
In this episode of the Elevate podcast series, MAPS speaks with experts about tackling the challenges of an expanding world and understanding who is communicating research by measuring Share of Voice.
In this our third episode this season, we’ll be discussing how and why medical publishing is changing and where is it going in the future.
MAPS speaks with Tim Mikelhashvili and winners of his Medical Affairs Innovation Olympics about applications that can match patients with clinical trials and provide real-time input to provide context for clinical decisions.
In this episode, we look at the tools that exist to look deeper into data allowing MedInfo teams to truly contribute to the generation, analysis of Medical Insights.
MAPS speaks with Tim Mikhelashvili, CEO and Co-Founder of Amedea Pharma, and the winners of his Medical Affairs Olympics Competition, the CEOs of Discreedly and Inphronesis.